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Functional Analysis of Substrate and Cofactor
Complex Structures of a Thymidylate
Synthase-Complementing Protein
drofolate (CH2H4folate) serves as both a methyl donor
and reductant in the reaction. Thymidylate synthesis is
the terminal step in the sole de novo synthetic pathway
to dTMP. Consequently, its inhibition stops DNA pro-
duction, arresting the cell cycle and eventually leading
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ogy to classical TS (thyA). The structure of TM04493 The San Diego Supercomputer Center
(2.25 A˚ resolution), solved by the Joint Center for Struc-9500 Gilman Drive
tural Genomics (Kuhn et al., 2002), revealed a novel fold.La Jolla, California 92093
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Dictyostelium discoideum, the thy1 gene is widely dis-10675 John Jay Hopkins Drive
tributed within the bacterial and archaeal domains ofSan Diego, California 92121
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served only in Mycobacterium tuberculosis and Myco-University of California, San Francisco
bacterium leprae. Most other TSCP-containing organ-San Francisco, California 94143
isms depend on thy1 for their survival. The absence
of homology between TSCP and classical thymidylate
synthase offers the possibility of developing specificSummary
inhibitors for these pathogenic microbes.
While the TSCPs convert dUMP to dTMP (MyllykallioLike thymidylate synthase (TS) in eukaryotes, the thymi-
et al., 2002), the details of the mechanism of TSCP catal-dylate synthase-complementing proteins (TSCPs) are
ysis are unknown. TS uses tetrahydrofolate as reductantmandatory for cell survival of many prokaryotes in the
and forms dihydrofolate as a product of the methylation
absence of external sources of thymidylate. Details of
reaction (Carreras and Santi, 1995). The dihydrofolate
the mechanism of this novel family of enzymes are is then rapidly reduced to tetrahydrofolate by dihydrofo-
unknown. Here, we report the structural and functional late reductase (DHFR). Recent studies have shown that
analysis of a TSCP from Thermotoga maritima and its TSCP activity depends on reduced flavin nucleotides
complexes with substrate, analogs, and cofactor. The and proposed a flavin-dependent mechanism (Myllykal-
structures presented here provide a basis for rational- lio et al., 2002). The mechanism proposed here suggests
izing the TSCP catalysis and reveal the possibility of a TSCP catalytic mechanism similar to that of the FADH2-
the design of an inhibitor. We have identified a new dependent ribothymidyl synthase (Delk et al., 1980).
helix-loop-strand FAD binding motif characteristic of These enzymes use CH2H4folate solely as a one-carbon
the enzymes in the TSCP family. The presence of a donor and employ FADH2 as the reducing agent. Our
hydrophobic core with residues conserved among the structural analysis confirmed the binding of FAD in the
TSCP family suggests a common overall fold. active site of TM0449 and supports the suggested flavin-
dependent mechanism.
Introduction To understand the mechanism of TSCP catalysis, we
crystallized and determined crystal structures of several
The thy1 gene of Thermotoga maritima encodes a thymi- complexes of TM0449 in the absence and presence of
dylate synthase-complementing protein (TSCP), TM0449, FAD, substrate, and substrate mimics. Discussed here
with a molecular weight of 26,005 Da (Lesley et al., 2002; are eight functionally relevant structures: FAD bound
Kuhn et al., 2002). TSCPs have been implicated in cell (1.8 A˚), FAD and PO4 (2.50 A˚), FAD and dUMP (1.6 A˚),
survival in the absence of external sources of thymidyl- FAD and FdUMP (2.0 A˚), FAD and BrdUMP (2.3 A˚), apo-
ate (Dynes and Firtel, 1989; Podgorski and Deering, enzyme (2.0 A˚), apoenzyme with dUMP (2.4 A˚), and apo-
1984). In general, TSCPs substitute the activity of thymi- enzyme with FdUMP (2.1 A˚) (Table 1). Analysis of the
dylate synthase (TS) enzymes in organisms lacking TS. crystal structures in conjunction with sequence data
During the thymidylate synthesis 2-deoxyuridine 5- for a number of TSCP enzymes identifies conserved
monophosphate (dUMP) gets methylated to produce 2- residues that are important for catalysis and strongly
deoxythymidine 5-monophosphate (dTMP), a nucleo- suggests that the TM0449-type fold is ubiquitous in the
TSCP/thy1 family. Detailed structural analysis showstide essential for synthesis of DNA (Carreras and Santi,
that the FAD binding site, which contains a new FAD1995). In TS, cofactor 5,10-methylene-5,6,7,8-tetrahy-
binding motif with a new fold, is preformed and rigid. A
bound HEPES buffer molecule in one of the structures*Correspondence: pkuhn@scripps.edu (P.K.), iimathew@stanford.
provides structural constraints and a possible startingedu (I.I.M.)
point for the development of drugs targeting this impor-6Present address: The Scripps Research Institute, CB227, 10550
North Torrey Pines, La Jolla, California 92037. tant family of enzymes.
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Table 1. Crystallographic Parameters, Data Collection, and Refinement Statistics
FAD bound FAD plus PO4 FAD plus dUMP FAD plus FdUMP
Crystallographic Parameters
Space group P212121 P212121 P212121 P212121
Unit cell dimensions (A˚) 54.50, 116.95, 141.60 54.99, 118.15, 145.40 55.56, 117.73, 141.88 54.64, 116.96, 141.93
Asymmetric unit tetramer tetramer tetramer tetramer
Data Collection Statistics
Resolution limits (A˚) 38.3–1.80 47.1–2.50 50.0–1.60 45.2–2.00
Number of observed reflections 331,090 96,569 530,608 264,891
Number of unique reflections 78,182 32,278 121,887 62,119
Completeness
Overall/outer shell 92.5/81.4 96.2/87.3 98.9/91.5 99.6/98.0
Rsyma (%)
Overall/outer shell and os I/ 4.5/23.9 and 3.1 8.0/46.9 and 1.5 7.1/53.9 and 1.2 6.8/42.9 and 1.8
Refinement Statistics
Resolution limits 20.0–1.80 20.0–2.50 20.0–1.60 20.0–2.0
Number of reflections/percentage (|F|2|F|) 77,627/91.7 32,148/94.3 120,909/98.1 61,604/99.0
Reflections used for Rfree 3,895 1,559 6,098 3,129
R factorb (%) 20.3 20.1 20.3 19.4
Rfree (%) 23.0 26.1 21.8 23.2
Model contents/average B (A˚2)
Protein atoms 7,109/29.6 7,138/38.4 7,333/32.3 7,268/31.7
Ligand atoms/buffer atoms 212/51.0 212/45.6 342/25.3 296/22.8
Ions 0 15/82.0 0 0
Water molecules 308/41.2 240/37.1 268/44.4 428/35.5
Rms deviations
Bond length (A˚) 0.006 0.008 0.008 0.006
Bond angle () 1.18 1.32 1.36 1.19
FAD plus Br dUMP Native (Form I) Native plus dUMP Native plus FdUMP
Crystallographic Parameters
Space group P212121 P212121 P212121 P212121
Unit cell dimensions (A˚) 54.35, 116.43, 140.56 54.48, 116.64, 142.25 54.68, 116.70, 141.73 54.39, 116.71, 141.00
Asymmetric unit tetramer tetramer tetramer tetramer
Data Collection Statistics
Resolution limits (A˚) 46.6–2.30 46.6–2.0 54.4–2.4 50.6–2.1
Number of observed reflections 226,323 275,520 134,682 161,945
Number of unique reflections 39,615 59,761 33,587 50,458
Completeness
Overall/outer shell 98.0/93.1 96.5/90.5 93.0/85.6 95.2/86.3
Rsym (%)
Overall/outer shell and os I/ 8.1/44.5 and 1.7 6.1/53.1 and 1.4 9.1/33.8 and 2.2 6.5/44.5 and 1.7
Refinement Statistics
Resolution limits 20.0–2.3 20.0–2.0 20.0–2.4 20.0–2.1
Number of reflections/percentage 39,284/97.2 59,344/95.6 33,242/91.8 49,793/93.6
Reflections used for Rfree 1,971 2,996 1,644 2,485
R factor (%) 18.8 20.7 19.9 19.3
Rfree (%) 23.0 25.2 26.3 24.0
Model contents/average B (A˚2)
Protein atoms 7,223/33.3 7,137/36.2 7,193/33.7 7,250/32.3
Ligand atoms/buffer atoms 296/29.3 0 80/36.9 184/36.9
Ions 0 0 0 0
Water molecules 201/36.2 408/42.9 225/34.9 338/38.1
RMS deviations
Bond length (A˚) 0.007 0.006 0.006 0.006
Bond angle () 1.22 1.23 1.22 1.22
a Rsym  |Iavg  Ii|/Ii.
b R factor  |Fp  Fpcalc |/Fp, where Fp and Fpcalc are the observed and calculated structure factors; Rfree is calculated with 5% of the data.
Results formation by FAD-bound TM0449 required the presence
of CH2H4folate and a reduced pyridine nucleotide, NADH
or NADPH. Removal of CH2H4folate from the reactionThymidylate Synthase Activity of TM0449
Conversion of radioactive dUMP to dTMP by TM0449 mixture abolished the formation of the product, dTMP.
Removal of both the pyridine nucleotides from the reac-was monitored by a TLC-based assay (Figure 1A). dTMP
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Figure 1. TSCP Activity of TM0449
(A) Reverse-phase TLC profile of the TM0449
reaction mixture showing dTMP formation.
“Complete” reaction mixture contained 100
mM Tris-HCl (pH 8.0), 10 mM MgCl2, 0.19 mM
[2-14C] dUMP (52 Ci/1 mol), 0.5 mM each
of CH2H4 folate, NADH, and NADPH, and13
M (monomer) FAD-bound enzyme. Individ-
ual components were omitted from the reac-
tion mixture as indicated.
(B) Effect of temperature on the TSCP activity
of TM0449.
(C) Effect of exogenously added FAD on
TM0449 reaction. A total of 0.5 mM FAD was
added to the complete reaction mixture con-
taining the FAD-bound or FAD-free enzyme.
tion mixture also abolished the activity, which could 2E). The long axis of each monomer makes a tilt of12
with the long axis of the oval, resulting in the oval shape.be restored by adding either NADH or NADPH. This
suggests that TM0449 activity requires a reduced pyri- The total surface area buried by the creation of the
tetramer is 2000 A˚2 per monomer.dine nucleotide but that the enzyme does not strictly
differentiate between NADH or NADPH and can use ei-
ther of these cofactors for the reaction. Similar results FAD Binding Site
are also reported for the Helicobacter pylori thy1/thyX The absolute requirement of FAD for the reaction and
enzyme (Myllykallio et al., 2002). TM0449 also shows the successful crystallization of complexes with FAD
dUMP to dTMP conversion at 47C, 57C, and 67C (Fig- and substrate show that FAD binding is essential for
ure 1B). TSCP catalysis. Therefore, an analysis of the FAD bind-
Addition of exogenous FAD appeared to inhibit the ing observed in the crystal structure is crucial for an
enzymatic activity (Figure 1C). This is in contrast to Heli- understanding of the TSCP reaction mechanism. The
cobacter pylori thy1, which, despite the presence of catalytic function of FAD derives from the isoalloxazine
bound flavin, required exogenously added flavin nucleo- (flavin) ring, whereas the ribityl phosphate and the AMP
tide for optimal activity (Myllykallio et al., 2002). The moiety mainly stabilize cofactor binding to protein resi-
FAD-free form of TM0449 showed little or no activity in dues. There are four FAD molecules present in the
this qualitative assay, but the enzyme catalyzed the TM0449 tetramer (Figures 2D and 2E). Paired FAD mole-
dTMP formation upon addition of FAD (Figure 1C). This cules lie in a large groove running along the long edges
data confirms that a flavin nucleotide is an essential of the tetramer, where they interact with each other
component of the TM0449-mediated formation of dTMP. through the ribose portion of the AMP moiety. However,
the adenine rings point away from each other. The FAD
molecules are in the elongated conformation, and theOverall Structure of TM0449
The crystal structure of TM0449 shows that the enzyme flavin rings of each interacting pair of FAD molecules are
29 A˚ from each other. There are no direct interactionsis a tetramer with four identical subunits (220 residues)
that extensively interact with each other. Each monomer between the two pairs of FAD molecules on each side
of the tetramer. The adeninine rings of all FAD moleculesconsists of a central 	/
 domain and two 	 helices lo-
cated away from the central domain (Figures 2A and are buried deep inside the tetramer, with the amino
groups pointing to the interior of the protein. The dis-2C). The central domain contains a five-stranded anti-
parallel 





4 (Fig- tance between the adenine amino nitrogen and a C	
on the surface directly above is 22 A˚. However, theure 2B). These sheets are curved toward the main body
of the subunit. Four helices (	3, connecting 
3 and 
5, catalytically important flavin ring is exposed to the sur-
face of the tetramer (Figures 2D and 2E).and C-terminal helices 	6, 	7, and 	8) flank the inside
of the curved sheet. This forms the core of the subunit. Analysis of the interactions between FAD molecules
and the protein shows that FAD is well bound (Figures 3ATwo of the helices, 	4 and 	5, are separated from the
central domain. 	 helix 4 is 26 residues long and gives and 3B). Each of the FAD molecules makes an average
of 42 interactions (3.5 A˚) with the tetramer. Of thesea distinct appearance to the monomer (Figure 2C). The
view from one face of the tetramer resembles a rectan- interactions, 13 are hydrogen bonds involving nine resi-
dues (Figure 3B). Most of the residues involved in thegular box with edges of 51 A˚  86 A˚ and a thickness of
53 A˚ (Figure 2D). The orthogonal view is oval shaped, hydrogen bonding interactions are either conserved or
show similar side chain character (see below; Figurewith a pair of long helices at the edges of the oval (Figure
Structure
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Figure 2. Structure of TM0449
(A) View of the monomer.
(B) Topology diagram of the monomer (Westhead et al., 1998). 
 strands, filled black triangles; 	 helices, filled blue circles. Strand directions
are indicated using upward-pointing or downward-pointing triangles. N and C termini are labeled.
(C) View of the monomer orthogonal to the view in (A).
(D) View of the tetramer showing bound FAD molecules. Flavin ring exposed to the surface in one of the monomers is shown with an arrow.
(E) Orthogonal view of the tetramer. The paired FAD molecules on each side of the tetramer, cyan and black.
5C). The flavin ring of FAD is either disordered or shows ure 3B). While the AMP phosphate hydrogen binds solely
with monomer C, the pyrophosphate moiety hydrogenvery weak electron density in the structures without sub-
strate or substrate mimics. Most of the hydrogen bonds bonds to both monomers A and C. All three monomers
(A, C, and D) participate in the hydrogen bonding interac-to FAD are directed to the two phosphate groups. While
the pyrophosphate oxygens interact through four hydro- tions with the riboflavin moiety. The planarity of the flavin
ring and the yellow color of the FAD-containing crystalsgen bonds, the phosphate of the AMP moiety uses three
hydrogen bonds for its interactions (Figure 3B). Further- show that the flavin ring is in the oxidized state.
Structural comparison of the complexes shows thatmore, one of the oxygens of this AMP phosphate inter-
acts with three protein residues through a strongly the FAD binding site of TM0449 is preformed. The struc-
tures of the complexes with and without FAD superim-bound water molecule. The adenine base and the ribose
moiety each make one direct hydrogen bond with the pose on each other with an rmsd of 0.3 A˚ for 841 C	
atom pairs, and no major tertiary changes are detectedprotein residues. The riboflavin moiety hydrogen bonds
to four protein residues. In the complexes with substrate in the overlap. Furthermore, the positions of the side
chains of all of the residues involved in FAD binding areor substrate mimics, the pyrimidine ring of the substrate
stacks with the flavin ring. In the enzyme-FAD-dUMP well preserved. In the structures without FAD, bound
water molecules or atoms of buffer molecule replacecrystal structure, a PEG molecule occupies the extra
space on the opposite side of the flavin ring (Figure 3A). most of the FAD atoms that were involved in hydrogen
bonding interactions with the protein molecule. There-Interestingly, three monomers contribute significantly
to each FAD binding site (Figure 3B). Of the 13 hydrogen fore, even though FAD is very well bound to three sub-
units, FAD interactions are not an absolute requirementbonds present in each FAD binding site, 2 are from one
monomer, 5 are from the second monomer, and the rest for tetramer stabilization.
are from the third monomer. The adenine base is stacked
on one side against the side chain of isoleucine 81 from Substrate Binding Site
The crystal structures of the complexes with substratemonomer C and on the opposite side against the carbox-
ylate-guanidinium plane of the doubly hydrogen bonded (dUMP) and substrate mimics establish the location of
the substrate binding site. The substrate is positionedE58 (from monomer C) and R80 (from monomer A) (Fig-
Functional Analysis of a thyX/thy1 Enzyme
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next to the catalytically active flavin ring of FAD, and the substrate, substrate mimics, or PO4, the substrate
binding loop is generally disordered. The conformationalthe pyrimidine ring stacks to the flavin ring (Figure 3C).
Substrate binds predominantly to the flexible 90 loop changes of the substrate binding loop create the phos-
phate binding site and bring important residues to hy-(residues 86–97) containing conserved residues. Sub-
strate is well bound and makes a network of 11 direct drogen bonding distance to the substrate. The distance
between the C	 atoms of R90 in the two conformationshydrogen bonding interactions with the protein (Figures
3C and 3D). Of these interactions, seven are from one of the substrate binding loop is 7.4 A˚. In addition to
the conformational stabilization of the substrate bindingsubunit and the remainder from the second subunit.
Since the flexible 90 loop plays an important role in loop, structural comparisons also revealed a conforma-
tional change of the 30 loop (residues 27–37) (Figure 4C)substrate binding by providing three side chain and two
main chain hydrogen bonds, we designate it the “sub- of the neighboring monomer. Even though the 30 loop
does not directly interact with the substrate, it shows astrate binding loop.” In complexes without substrate or
substrate mimics, the substrate binding loop is either concerted movement with substrate binding. This move-
ment affects the residues from V29 to K36, whereasdisordered or adopts multiple conformations. The elec-
tron density for the substrate loop is very weak in all of residues 30–32 show a loop to 310 helix transition during
the conformational change (Figure 4C). The chain direc-the complexes without substrate or substrate mimics.
Six of the eight residues that hydrogen bond to the tions completely change at residue 29, and this change
swings the C	 carbon of the next residue (S30) by aroundsubstrate (R78, R80, S88, R90, R147, and R174) are well
conserved among members of the TSCP family (see 9 A˚, bringing the side chain of S30 within hydrogen
bonding distance to one of the flavin ring oxygen atomsbelow; Figure 5C). While the seventh residue (Q75) pre-
serves the side chain character among the members, (Figure 4D).
The conformational change of the 30 loop also bringsthe eighth residue (G89) contributes only a main chain
interaction. Therefore, as observed in the case of the the side chain of F31 close to the flavin binding site
and the side chain of Y91 (Figure 4D). The hydrophobiccofactor FAD binding, the substrate binding site is also
conserved among the TSCP family members. The 2 and character of F31 is almost fully conserved (predomi-
nantly Y or W) among the members of the TSCP family.3 positions of the pyrimidine ring moiety participate in
a double hydrogen bonding interaction with the R174 The Y91 residue is also well conserved among the TSCP
family members (see below; Figure 5C). The conforma-residue from one subunit, while the carbonyl oxygen at
the 4 position hydrogen bonds to R90 of the substrate tional changes of the substrate binding loop and the 30
loop together tilt the plane of the flavin ring by aroundbinding loop of the neighboring subunit (Figure 3D). Ad-
ditional interactions from the conserved E144 stabilize 10, making its hydrogen bonding interactions with the
main chain atoms more directional and stronger. There-the orientation of the R90 side chain. R174 is stabilized
by a hydrogen bond from H79 of the conserved RHR fore, we propose that the substrate-induced conforma-
tional changes play an important role in the catalyticmotif. The oxygen at the pyrimidine 4 position also inter-
acts with three protein residues through a water mole- mechanism. In the active-like conformations, the car-
bonyl oxygen of S30 in the 30 loop hydrogen bonds tocule (Figure 3D). The hydroxyl group of the ribose makes
a bifurcated hydrogen bonding interaction with the NH2 amide nitrogen of S88 in the substrate binding loop.
of R78 (the first arginine of the RHR sequence motif)
from one subunit and one of the oxygens (O1) of a
Discussionglutamate carboxylate (E86) from the other subunit (Fig-
ure 3D). The phosphate group makes five direct hydro-
Structural Organization of TSCP Familygen bonding interactions utilizing three of its oxygen
The structure of the TM0449 monomer reveals the pres-atoms. Phosphate interactions are also contributed from
ence of a central hydrophobic core contributed by 21-two distinct monomers (Figure 3D). Phosphate oxygens
amino acid side chains (Figures 5A and 5B). The hy-form two main chain and one side chain hydrogen bond
drophobic core is formed by two residues from 
2, fourwith the substrate binding loop. One of the hydrogen
residues from 
3, one residue from 
4, three residuesbonds is provided by the side chain of the highly con-
from 
5, four residues from 	3, three residues from 	6,served S88 (see below; Figure 5C). Mutational studies
and three residues from 	7. Therefore, all of the second-in Helicobactor pylori have shown that substitution of
ary-structural elements from the central core of theS107 (which corresponds to S88 in TM0449) to Ala abol-
monomer contribute to the hydrophobic core. The nu-ishes the TSCP activity (Myllykallio et al., 2002). A single
cleus of the hydrophobic core is a nine-residue centralhydrogen bond by the side chain of E75 from one sub-
region (residues almost fully buried). Residues for theunit, a double hydrogen bond by the R147 side chain




5, 	3, 	6, and 	7. The hydrophobic coretion complete the hydrogen bonding sphere of the phos-
appears to preserve the structural integrity of the mono-phate group. As expected, the substrate interactions
mer and stabilizes the novel fold of TM0449.are also preserved in the complexes of TM0449 and
Detailed analysis of 61 sequences of TSCP familysubstrate mimics with or without FAD. There is good
members shows conservation of 17 of the 21 residuesdensity for dUMP or its mimics for all the structures of
forming the hydrophobic core (Figure 5C). The remainingthe complexes with these ligands (Figures 3E and 3F).
four residues generally show hydrophobic character.
The conservation of residues in the hydrophobic coreSubstrate-Induced Conformational Changes
within the TSCP family and the prominent location ofThe binding of substrate stabilizes the flexible substrate
binding loop (Figures 4A and 4B). In complexes without these residues in the TM0449 structure suggest that the
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Figure 3. Binding of FAD, Substrate, and Substrate Mimics
(A) Fo  Fc omit electron density for FAD (density from complex with FAD and dUMP) at 2.0  generated after a cycle of simulated annealing
without including FAD in the refinement (same procedure was used for generating other electron density maps). The PEG molecule present
on one side of the flavin ring, yellow.
(B) Stereoview of the hydrogen bonding interactions of FAD with the protein. Part of the neighboring FAD molecule is shown with gray bonds.
Secondary-structural elements of monomers A, C, and D discussed in the paper are colored green, blue, and red, respectively. Water molecules,
cyan spheres.
(C) Fo  Fc omit electron density for substrate dUMP at 2.0 . Flavin ring stacking to the pyrimidine ring is shown in green.
(D) Stereoview of the hydrogen bonding interactions of the substrate with the protein. Secondary-structural elements are colored as in (A).
Water molecules, cyan spheres.
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Figure 4. Substrate-Induced Conformational
Changes
(A) View of the conformational changes of the
substrate binding loop. Substrate stabilized
conformation, green.
(B) View of the substrate binding conforma-
tional change showing the residues of the sta-
bilized conformation.
(C) View of the conformational changes of the
substrate binding loop and 30 loop. Stabilized
conformations, green; secondary-structural
elements from the second monomer, purple.
(D) View showing the residues from the stabi-
lized conformation. Residues F31 and Y91 are
labeled.
presence of the hydrophobic core is a common feature moiety binds to the most strongly conserved sequence
motif (Dym and Eisenberg, 2001).among all TSCP family members. It has long been recog-
nized that buried hydrophobic side chains are one of The FAD binding fold observed in TM0449 is shown
in Figure 6B. The structure shows a novel structuralthe principal forces for the structural stability of proteins
(Kauzmann, 1959). Also the presence of a hydrophobic organization for the FAD binding site. The binding of
two FAD molecules to either side of a large bindingcore has been implicated in the stability of a number of
proteins (Munson et al., 1996; Frank et al., 2002). Some site contributed by two protein subunits has not been
observed before (Figure 6B). A detailed view of the bind-studies have also suggested that the physical forces
driving aggregation of hydrophobic molecules in water ing site shows that three protein subunits participate in
the binding of each of the FAD molecules (Figure 6C).are responsible for protein folding (Tsai et al., 1997).
Consistently with this background information, the hy- In other crystal structures of FAD binding proteins, FAD
generally binds to only one subunit, with the exception ofdrophobic core present in the TM0449 structure is likely
characteristic of this new fold and applies to all members quinone oxidoreductase (Foster et al., 1999) and acetyl-
CoA dehydrogenase (Tiffany et al., 1997).of the TSCP family.
The uniqueness of the FAD binding domain in TM0449
is also revealed in the binding sequence motif. Our anal-Novel FAD Binding Domain
The recent analysis of the structure-sequence relation- ysis of the 61 identified members of the TSCP family
failed to identify a conserved sequence motif that is alsoships in 32 families of FAD binding proteins has revealed
four different FAD family folds (Dym and Eisenberg, present in any of the four FAD family folds (Dym and
Eisenberg, 2001). Furthermore, the binding characteris-2001). These folds are represented by the glutathione
reductase (GR) family, the ferrodoxin reductase (FR) tics of the TM0449 FAD binding domain are different
from the other single-membered FAD binding proteinfamily, the p-cresol methylhydroxylase (PCMH) family,
and the pyruvate oxidase (PO) family (Figure 6A). These families (Foster et al., 1999; Tiffany et al., 1997; Park et
al., 1995; Guenther et al., 1999). A comparison of thestudies have also shown that each FAD fold can be
uniquely identified by the presence of distinctively con- thy1 sequences showed a new conserved sequence
motif, E(Q)hxRHRx(7,8)hxhS(N,T,D,Q)xxSxRY(F) (resi-served sequence motifs and that the pyrophosphate
(E) Fo  Fc omit electron density for BrdUMP.




Figure 5. Conserved Hydrophobic Core of
TM0449
(A) View of the hydrophobic core in the mono-
mer. Residues in the central core, red.
(B) Close-up view of the hydrophobic core.
(C) Results from the alignment of the thy1
sequences shown with TM0449 sequence
numbering and TM0449 secondary-structural
elements (
 strands, green arrows; 	 helices,
cyan rods; 310 helices, purple rods). Residues
conserved for90% between the sequences
are shown in red. Hydrophobic residues
showing similar conservation (90%) are
shown with lowercase “h.” Residues showing
a major trend toward a specific amino acid
are shown with their amino acid letter in low-
ercase. Residues with some general trend
(e.g., all hydrophilic) are shown with a number
sign (#). Residues showing functional impor-
tance (interaction) in the crystal structure are
shown in the bottom line. Residues contribut-
ing to the hydrophobic core, filled green trian-
gles; residues involved in the central core,
green triangles with red outlines; residues in-
volved in FAD binding, filled blue diamonds;
residues involved in substrate binding, open
diamonds; residues involved in both FAD and
substrate binding, filled blue diamonds with
a red dots.
dues 75–91 in TM0449), characteristic of the side by sequence motif is present in a helix-loop-strand motif
(residues 76–86). Because of the uniqueness of the inter-side binding of FAD molecules. The histidine in position
5 of the motif is conserved in 27 out of 28 sequences; actions, we propose that the helix-loop-strand motif is
common for the TSCP enzyme family.it is replaced by a threonine in one instance. Also in a
single instance, the arginine in the C-terminal end is
replaced by a cysteine. All three hydrophobic residues Comparison with Thymidylate Synthase
TS is a structurally and functionally well-understood en-of the motif participate in the hydrophobic core inside
the monomer (Figure 5C). While the first arginine of the zyme family (Carreras and Santi, 1995; David et al., 1997;
Stroud and Finer-Moore, 1993). Thymidylate synthasesequence motif hydrogen bonds to one of the flavin ring
oxygens, the second arginine hydrogen bonds to both is an obligatory homodimer, and the overall fold of the
enzyme is preserved among species (Carreras andphosphate groups. The ninth residue of the sequence
motif is predominantly hydrophilic and hydrogen bonds Santi, 1995). Even though TS and TM0449 participate
in similar reactions, there is no structural or sequenceto glutamic acid of the double hydrogen bond partner.
Members of the 11th position are involved in aligning the similarity between them. However, as observed in the
case of TS, TSCP enzymes also seem to preserve theribitol moiety. In the TM0449 structure, the conserved
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Figure 6. FAD Binding Fold
(A) Representation of the FAD binding fold
observed in the four family members (taken
from Dym and Eisenberg, 2001). Distinct sec-
tions are shown in blue and red.
(B) View of the FAD binding fold observed in
the TM0449 structure. Secondary-structural
elements from the two subunits are colored
differently.
(C) View of the FAD binding fold showing the
secondary-structural elements from three
monomers that are contributing to each of
the FAD molecules.
overall fold among the members. A significant difference subunits. TS also shows a substrate-induced conforma-
tional change near the active site. However, unlike inbetween these enzyme families is the absence of the
active site cysteine in the TSCP structure. The active the TM0449 structure, the conformational change repo-
sitions only one of the arginine (R21) side chains tosite cysteine is crucial for the TS reaction (Stroud and
Finer-Moore, 1993; Phan et al., 2000). In both cases, the hydrogen bond interactions with the substrate. Another
difference between the structures is the number of argi-substrate dUMP interacts extensively with the enzyme
(Protein Data Bank code for structures used, 2TSC). nines interacting with the phosphate group. The TS
structure has four interacting arginines (two from eachHowever, it is noteworthy that, in TS, the phosphate
moiety binds only to the side chain atoms, whereas, in subunit), and the PO4 of TM0449 interacts with only
two arginines. Even though the arginines around thethe TM0449 structure, the phosphate is held rigid by
hydrogen bonding interactions with both main chain and phosphate binding region provide a favorable electro-
static environment for the phosphate moiety, studiesside chain atoms. Furthermore, while the pyrimidine ring
in TM0449 interacts exclusively with the side chain have shown that all four arginines of TS are not essential
for its activity (Kawase et al., 2000).atoms, in TS, the pyrimidine ring is also involved in
hydrogen bonding interactions with the main chain
atoms. Therefore, the pyrimidine ring of the substrate TSCP Catalysis
Although thymidylate synthase-complementing pro-in TM0449 could exhibit more flexibility during the reac-
tion. TSCPs may require this additional flexibility while teins (TSCPs) have been implicated in cell survival in
the absence of external sources of thymidylate, theiraccepting electrons and a methyl group from two differ-
ent molecules. In fact, a comparison of the structures mechanism of catalysis is not well understood. Studies
with the Helicobacter pylori thy1 gene product (Myllykal-of the enzyme-FdUMP complex and the enzyme-FAD-
FdUMP complex shows larger movements of the pyrimi- lio et al., 2002) and our studies on the activity of TM0449
confirm the absolute requirement of FAD, CH2H4folate,dine ring plane (3) with respect to the phosphate
anchor. and a reduced pyridine nucleotide in TSCP catalysis.
The resulting understanding is that TSCP catalysis isThe substrate binding site of TS is contributed by two
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similar to the reactions of folate-dependent ribothymidyl the O of S88 to only 3.3 A˚ from the 6 position of
dUMP. Thus, additional changes may occur during thesynthase (Delk et al., 1980). In these reactions, enzymes
use CH2H4folate solely as a one-carbon donor and em- CH2H4folate binding and catalysis.
ploy FADH2 as a reducing agent.
Potential Antibacterial Target
Although extremely rare in eukaryotes (present only in
Dictyostelium discoideum), TSCPs are widely distrib-
uted in the bacterial and archaeal domains of life, includ-
ing a number of pathogenic bacteria (Table 2). The ab-
sence of structural or sequence homology between thy1
enzymes and classical thyA thymidylate synthases of-
fers the possibility of developing highly specific thy1
inhibitors with low crossreactivity with the thyA thymi-
dylate synthase enzymes, hence a significantly reducedThe reduced flavin is generated by NAD(P)H. All our
risk of toxic effects to eukaryotes. The fold and activeattempts in crystallizing a complex of TM0449 with
site preservation suggested by the present study alsoCH2H4folate and folate analogs in the presence or ab-
lends itself to the possibility of designing a small mole-sence of FAD and/or substrates were unsuccessful.
cule inhibitor that could be effective against all thy1-Analysis of the structures also shows that the flavin
dependent organisms.ring of FAD in these complexes is in the oxidized form.
In general, substrate or cofactor mimics are used asHowever, the proposed reaction mechanism requires
enzyme inhibitors. However, in TSCP catalysis, sub-the flavin ring to be in the reduced state for the reaction.
strate mimics would inhibit classical thymidylate syn-The analysis of the structure in the context of the cataly-
thase, and the FAD mimics would affect many of thesis provides valuable insights toward understanding of
important enzymes that utilize FAD as the cofactor.the full mechanism.
Therefore, an ideal strategy for developing an inhibitorStructures of the apoenzyme and the enzyme-FAD
for TSCP will be to develop a compound that spans theform show that the binding of FAD is not required for
spatially close FAD and dUMP binding sites. Such athe stabilization of the tetramer. Therefore, a TSCP reac-
compound could be highly selective for only thy1 en-tion where the enzyme alternates between CH2H4folate
zymes.and FAD is conceivable. However, attempts to dock
Since thymidylate synthase (TS) is a very well-studiedCH2H4folate in the FAD binding site were unsuccessful,
enzyme family, inhibitors for the dUMP site are alreadyand the characteristics of the FAD binding pocket are
available. It has been reported that, in contrast to thenot favorable for the CH2H4folate group. In the struc-
diversity of the FAD fold in sequence and shape amongtures, the flavin ring of the FAD molecules binds to a
different families, the pyrophosphate moiety forms verylarge pocket that can also accommodate the reduced
specific hydrogen bonds with residues from the mostform of the flavin ring. Also the space around the flavin
conserved sequence motifs in each family (Dym andring can allow its movements. The enzyme may use the
Eisenberg, 2001). It has also been proposed that thestrong binding interaction of the AMPP part of the FAD
pyrophosphate moiety is crucial for molecular recogni-to the protein as an anchor to facilitate flavin ring move-
tion. The present structural studies with TM0449 showments during catalysis. It may also be noted that the
the binding of the phosphate oxygen to very conservedflavin ring is exposed to the surface, and the present
residues. They also show that the FAD binding site isstructural studies do not provide information about the
preformed in TM0449 and that FAD binding is not neces-role of the conserved H53 (Figure 5C) located close to
sary for the structural stabilization. Therefore, a com-the flavin ring.
pound that binds to the pyrophosphate group andThe substrate binding site is created by the substrate-
stretches to the substrate binding site should be aninduced conformational changes of the substrate bind-
effective inhibitor to all members of the thy1 family.ing loop. As discussed earlier, the phosphate group is
In the structure of the enzyme-FdUMP complex,locked by hydrogen bonding interactions from resi-
HEPES molecules from the crystallization buffer occupydues in the substrate binding loop. Product release after
each of the FAD binding sites. The best crystals for thisthe reaction may require additional conformational
complex were obtained with HEPES as the crystalliza-changes, and the substrate binding loop may cycle be-
tion buffer. The sulfate of the HEPES is located almosttween bound and native conformation during substrate
at the middle of the two phosphates of FAD (Figure 7A).binding and product release.
Furthermore, two of the oxygens of the sulfate groupThe substrate-induced conformational changes bring
make five hydrogen bonds to the enzyme (Figure 7B).plasticity to the active site region. The comparison
One of these oxygen atoms hydrogen bonds to two mainof different structures has identified conformational
main chain atoms (R78 O and R80 N) and the N atomchanges of two loops near the active site. Both of these
of R80 side chain. The hydrogen bonding from the otherconformational changes bring important conserved resi-
oxygen atom to NH2 of R80 results in a double hydrogendues into close proximity to the active site. Even though
bonding interaction (Figure 7B). As mentioned earlier,mutational studies in H. pylori (Myllykallio et al., 2002)
R80 is involved in the important double hydrogen bond-point to the absolute requirement of S107 (S88 in
ing to E58 from the second subunit. The second sulfateTM0449) for catalysis, suggesting that it may be the
catalytic nucleophile, side chain torsional rotation brings oxygen is also involved in a hydrogen bonding interac-
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Table 2. Epidemiological Impact of TSCP-Containing Human Pathogenic Bacteria
Organism Disease Comments and Incidence
Treponema pallidum Syphilis 10,000 new cases/year in the U.S; over 12 million cases/year worldwide;
subspecies of T. pallidum cause endemic syphilis and yaws
Treponema denticola Periodontal disease 80% of adults in the U.S. have periodontal disease at some time in their
lives; recent evidence links it to cardiovascular disease
Borrelia burgdorferi Lyme’s disease Approximately 15,000 new cases/year in the U.S.
Helicobacter pylori Gastritis/ulcers Incidence increases with age; 10% of the U.S. population suffers from
peptic ulcer disease; over $6 billion/year cost in the U.S.
Campylobacter jejuni Diarrhea 2.4 million cases/year in the U.S. (approximately 125 deaths/year); in 2000,
14% of infections were due to drug-resistant organisms
Chlamydia trachomatis Trachoma, trichiasis, 146 million infected, 6 million blinded, and 11 with trichiasis worldwide;
nongonococcal urethritis 3 million cases/year in the U.S.; 40% of infected women develop PID
Chlamydia pneumoniae Pneunomia Associated with many other respiratory diseases and syndromes; 50,000
patients hospitalized every year in the U.S.
Chlamydia psittaci Psittacosis Sequels include endocarditis, hepatitis, and neurologic problems;
approximately 50 cases/year in the U.S; many more may occur that are
not reported
Mycobacterium tuberculosis Tuberculosis 3.5 million deaths/year wordwide; Increasing incidence of MDR
Mycobacterium leprae Leprosy Approximately 750,000 cases worldwide; 1–2 million people permanently
disabled worldwide; 91 cases in the U.S. in 2000
Mycobacterium bovis Bovine tuberculosis Opportunistic infection in HIV patients
Mycobacterium avium Avian tuberculosis Opportunistic infection in HIV patients
Corynebacterium diphteriae Diphteria Rare in the U.S. (0–5 cases/year); endemic in developing countries; over
150,000 in epidemic in former Soviet Union countries since 1990
Clostridium botulinum Botulism Potential biological warfare agent; approximately 200 cases/year in the U.S.
Clostridium difficile AAC diarrhea 4%–12% of diarrhea in HIV patients
Clostridium perfringens Food poisoning, gas gangrene Potential biological warfare agent; over 10,000 food poisoning cases/year
in the U.S.
Bacillus anthracis Anthrax Potential biological warfare agent; 25%–75% fatality rate for
gastrointestinal anthrax; 90%–100% for inhalation anthrax
Rickettsia prowazekii Epidemic typhus Potential biological warfare agent; during WWI 25 million Russians
contracted the disease, causing over 3 million deaths
Rickettsia connorii Mediterranean spotted fever Potential biological warfare agent; organism related to Rocky Mountain
spotted fever (Rickettsia rickettsia), whose U.S. incidence is 800
cases/year
Erhlichia chaffeensis Human monocytic erhlichiosis Approximately 50 cases/year in the U.S.
Rhodococcus sp. Necrotizing pneumonia Opportunistic infection in HIV patients; a few hundred cases/year;
50%–55% mortality rate
The sources for this table are the Centers for Disease Control and Prevention (http://www.cdc.gov) and the World Health Organization (http://
www.who.int).
tion with the NH2 of a conserved R165 from the second Biological Implications
Like thymidylate synthase (TS) in eukaryotes, the thymi-subunit. The third sulfate oxygen atom interacts with
the main chain amide nitrogen atom of R81 through a dylate synthase-complementing proteins (TSCPs) are
mandatory for cell survival of many prokaryotes in thewater molecule. Therefore, the sulfonic acid moiety of
HEPES satisfies most of the important hydrogen bond- absence of external sources of thymidylate. In these
organisms TSCPs substitute the activity of TS. Thymi-ing requirements of the FAD phosphates. The hydroxy-
ethylpiperazine portion aligns along the ribitol moiety of dylate synthesis is the terminal step in the sole de novo
synthetic pathway to dTMP, and the TS inhibition resultsFAD, and the hydroxyethyl group occupies the position
of the central ring of the flavin moiety (Figure 7A). How- in “thymineless” cell death. TSCPs employ a novel FAD-
dependent reaction for thymidylate synthesis (Myllykal-ever, there are no contacts (3.5 A˚) between the hy-
droxyethylpiperazine moiety and the protein residues. lio et al., 2002), and the mechanism is not well under-
stood.This suggests the possibility of using the position of the
sulfate group of HEPES and the position of the substrate To understand the mechanism of TSCP catalysis, we
performed detailed structural studies of a TSCP fromfor the design of a specific inhibitor for thy1 enzymes.
Using the coordinates of the HEPES molecule and the Thermotoga maritima. Multiple complexes with and
without FAD, substrate, and substrate analogs havecoordinates of 1-ethoxymethyl-5-flurouracil (derived
from the 6-benzyl-1-ethoxymethyl-5-isopropyl uracil co- mapped out many of the principal binding determinants
of this novel enzyme class. The structural study revealsordinates from Protein Data Bank entry 1RT1 [Hopkins
et al., 1996]), we modeled an inhibitor into the active site an important hydrophobic core characteristic of the
novel protein fold observed in the TM0449 structure,of TM0449. This inhibitor satisfies most of the hydrogen
bonding requirements of HEPES and the pyrimidine ring and the conservation of the residues participating in the
hydrophobic core suggests a TM0449-type fold for theof dUMP (Figure 7C). The molecular weight of the mod-
eled inhibitor is 378. TSCP family members. The present study has also iden-
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Figure 7. Binding of the HEPES Molecule
and the Modeled Inhibitor
(A) Overlap of the HEPES molecule (red) in
the enzyme-FdUMP structure and FAD (gray)
in the enzyme-FAD-dUMP structure. FdUMP
of the enzyme-FdUMP complex, blue.
(B) Hydrogen bonding interactions of the
HEPES molecule. Secondary-structural ele-
ments from different monomers are colored
similar to those in Figures 2B and 2D. Water
molecule, cyan sphere.
(C) The modeled inhibitor is shown with atoms
colors and thicker bonds. HEPES and FdUMP
present in the crystal structure are labeled.
Protein atoms are shown with a surface rep-
resentation. The ligand interactions with the
protein have been energy minimized with a
minimization protocol in the CNS programs.
(monomer) enzyme. Reaction was carried out at 37C for 3 hr, aftertified a novel FAD binding motif that is conserved within
which the reaction mixture was extracted with phenol:chloroform.the TSCP family. The binding of the substrate induces
One microliter of the aqueous phase was applied on a C18 reverse-movements of two loops near the active site. From a
phase TLC plate (Analtech, DE). TLC was developed in 0.05% tetra-
comparison of the structures with buffer molecules butylammonium hydrogen sulfate as the mobile phase. After drying,
bound at the FAD binding site, we were able to propose the TLC plates were scanned and visualized with a STORM 840
phosphorimager (Molecular Dynamics). Nonradioactive dUMP anda method for the design of an inhibitor for the TSCP
dTMP were used as standards and were visualized in UV light onfamily of enzymes. Since TSCP/thy1 is structurally unre-
the fluorescent TLC plates. In experiments where the effect of exog-lated to thyA thymidylate synthase and some of those
enously added FAD was monitored, 0.5 mM FAD was added to thebacterial organisms are poorly responsive to conven-
reaction mixture.
tional therapies, the development of specific and selec-
tive inhibitors for thy1 could provide highly effective Preparation of the Apoenzyme
tools for therapeutic intervention with low crossreactiv- TM0449 always purified in the FAD-bound form. The FAD-free form
was prepared by treating it with saturating amounts of NaCl in theity against mammalian thyA enzymes.
presence of buffer solution (20 mM Tris-HCl [pH 8.0] and 2 mM
2-mercaptoethanol). The protein was first precipitated with NaCl. ItExperimental Procedures
was then slightly warmed (40C) and centrifuged at 13,000 rpm. The
precipitated protein was washed several times with saturated NaClProtein Expression and Purification
solution and then dissolved in the buffer solution. The excess NaClTM0449 (GenBank accession number NP-228259) was expressed
was removed by repeated buffer exchange with Centricon concen-and purified by the previously described method (Kuhn et al., 2002).
trators.
Thymidylate Synthase Activity Assay
dTMP formation by TM0449 was qualitatively monitored by a re- Crystallization
Orthorhombic crystals of the apoenzyme were obtained from theverse-phase thin-layer chromatography (TLC) assay. Complete re-
action mixture contained 100 mM Tris-HCl (pH 8.0), 10 mM MgCl2, crystallization conditions reported for the enzyme-FAD-bound form
(Kuhn et al., 2002). Because of the unfavorable packing interactions0.19 mM [2-14C] dUMP (52 Ci/1 mol) (Moravek Biochemicals, CA),
0.5 mM each of CH2H4folate, NADH, and NADPH, and 13 M observed in the crystal structure, all of the complexes were prepared
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